NASDAQ:AKER Shareholder Notice: Lawsuit Alleges Misleading Statements by Akers Biosciences, Inc
June 25, 2018 at 13:00 PM EDT
San Diego, CA -- (SBWIRE) -- 06/25/2018 -- An investor, who purchased shares of Akers Biosciences, Inc. (NASDAQ: AKER), filed a lawsuit over alleged violations of Federal Securities Laws by Akers Biosciences in connection with certain allegedly false and misleading statements.
